Showing results (401-410 of 451) with videos related to

Sort By:
Pageof 46
Iscience|December 13, 2023
A tumor microenvironment-associated circRNA predictor for tumor relapse and chemotherapy vulnerability in nasopharyngeal carcinomaYe-Lin Liang, Yu-Heng Zhao, Cong Ding, et al.
Cells|May 24, 2024
Correction: Zhao et al. Hypermethylation of UCHL1 Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN). <i>Cells</i> 2020, <i>9</i>, 559Yin Zhao, Yuan Lei, Shi-Wei He, et al.
Cells|March 4, 2020
Hypermethylation of <i>UCHL1</i> Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN)Yin Zhao, Yuan Lei, Shi-Wei He, et al.
Plos One|September 27, 2013
SLC25A13 gene analysis in citrin deficiency: sixteen novel mutations in East Asian patients, and the mutation distribution in a large pediatric cohort in ChinaYuan-Zong Song, Zhan-Hui Zhang, Wei-Xia Lin, et al.
Cell Death & Disease|February 6, 2024
Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinomaXue-Liang Fang, Qing-Jie Li, Jia-Yi Lin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 31, 2021
Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trialSi-Qi Tang, Lei Chen, Wen-Fei Li, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2022
Adjuvant Apatinib in Nasopharyngeal Carcinoma With Residual Epstein-Barr Virus DNA After Radiation Therapy: A Biomarker-Driven, Phase 2 TrialXu Liu, Ling Guo, Fang-Yun Xie, et al.
The Lancet. Oncology|March 3, 2022
Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trialLing-Long Tang, Cheng-Long Huang, Ning Zhang, et al.
Med (New York, N.Y.)|July 12, 2025
Association of anti-PD-1 therapy with severe radiation-induced oral mucositis: A retrospective cohort study and validation in the CONTINUUM trialShi-Qian Zou, Cheng-Long Huang, Jing-Jing Zhang, et al.
Iscience|August 7, 2024
A radiogenomic clinical decision support system to inform individualized treatment in advanced nasopharyngeal carcinomaXue-Liang Fang, Lian-Zhen Zhong, Wei Jiang, et al.
Pageof 46